Solventum Corporation (SOLV) PEG Ratio: 0.04
Is Solventum Corporation’s PEG ratio high or low?
Solventum Corporation's PEG ratio of 0.04 is 100% below its 4-year average of 78.52, near the low end of its 4-year range (0.04–235.19).
In line with its 12-month average of 0.04.
SOLV PEG Ratio Chart
SOLV Average PEG Ratio Chart
SOLV Current vs Average PEG Ratio Chart
SOLV PEG Ratio Metrics
PEG RATIO
0.04
PEG RATIO AVG TTM
0.04
PEG RATIO AVG 3Y
117.61
PEG RATIO AVG 5Y
78.52
PEG RATIO AVG 10Y
78.52
PEG RATIO AVG 15Y
78.52
PEG RATIO AVG 20Y
78.52
CURRENT VS TTM AVG
+0.00%
CURRENT VS 3Y AVG
-99.97%
CURRENT VS 5Y AVG
-99.95%
CURRENT VS 10Y AVG
-99.95%
CURRENT VS 15Y AVG
-99.95%
CURRENT VS 20Y AVG
-99.95%
SOLV Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 0.04 | 0.04 | 117.61 | 78.52 |
| Align Technology, Inc. (ALGN) | $12.64B | 51.80 | 51.80 | 26.80 | 17.90 |
| Baxter International Inc. (BAX) | $10.58B | N/A | 0.18 | 0.70 | 1.43 |
| Hologic, Inc. (HOLX) | $16.97B | N/A | 0.30 | 0.22 | 1.95 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | N/A | 0.04 | 0.51 | 2.58 |
| Tempus AI, Inc. (TEM) | $8.65B | N/A | 0.61 | 1.49 | 1.49 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | N/A | 0.10 | 0.17 | 0.14 |
| Moderna, Inc. (MRNA) | $19.70B | N/A | 0.18 | 0.14 | 0.14 |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | N/A | 0.83 | 0.68 | 0.68 |
| BioNTech SE (BNTX) | $22.39B | N/A | 0.23 | 0.12 | 0.12 |
Growth-Adjusted Valuation
PEG Ratio
0.04
P/E Ratio
9.7
Solventum Corporation PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation PEG Ratio FAQ
- What is the PEG ratio for Solventum Corporation (SOLV)?
- The PEG ratio for SOLV stock is 0.04.
- Is Solventum Corporation's PEG ratio high or low?
- Solventum Corporation's PEG ratio of 0.04 is 100% below its 4-year average of 78.52, near the low end of its 4-year range (0.04–235.19).
- What is the TTM average PEG ratio for Solventum Corporation (SOLV)?
- The TTM average PEG ratio for SOLV stock is 0.04.
- What is the 3Y average PEG ratio for Solventum Corporation (SOLV)?
- The 3Y average PEG ratio for SOLV stock is 117.61.
- What is the 5Y average PEG ratio for Solventum Corporation (SOLV)?
- The 5Y average PEG ratio for SOLV stock is 78.52.
- What is the 10Y average PEG ratio for Solventum Corporation (SOLV)?
- The 10Y average PEG ratio for SOLV stock is 78.52.
- What is the 15Y average PEG ratio for Solventum Corporation (SOLV)?
- The 15Y average PEG ratio for SOLV stock is 78.52.
- What is the 20Y average PEG ratio for Solventum Corporation (SOLV)?
- The 20Y average PEG ratio for SOLV stock is 78.52.
Solventum Corporation PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 0.04 |
| 2023-12-31 | 235.19 |
| 2021-12-31 | 0.33 |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson